UMIN-CTR Clinical Trial

Recruitment status Main results already published
Unique ID issued by UMIN UMIN000030929
Receipt No. R000035321
Scientific Title Non-inferior comparative study comparing One or Two day antimicrobial prophylaxis in clean orthopaedic surgery
Date of disclosure of the study information 2018/04/01
Last modified on 2022/01/25 (Ver. 13)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Non-inferior comparative study comparing One or Two day antimicrobial prophylaxis in clean orthopaedic surgery
Acronym NOCOTA study
Scientific Title Non-inferior comparative study comparing One or Two day antimicrobial prophylaxis in clean orthopaedic surgery
Scientific Title:Acronym NOCOTA study
Region
Japan

Condition
Condition Clean orthopedic surgeries which required hospitalization
Classification by specialty
Orthopedics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Compare the effectiveness of preventive antibiotics within 24 hours and within 24-48 hours after clean orthopedic surgery
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Surgical site infections, urinary tract infections, respiratory tract infections, or other infections which required the use of antibiotics within 30 days after orthopedic surgery
Key secondary outcomes other adverse events

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Cluster
Blinding Open -no one is blinded
Control Active
Stratification NO
Dynamic allocation NO
Institution consideration Institution is considered as a block.
Blocking YES
Concealment Pseudo-randomization

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Administration of prophylactic antibiotics within 24 hours after surgery
Interventions/Control_2 Administration of prophylactic antibiotics within 24-48 hours after surgery
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1) aged 20 years or older,
2) hospitalized patients,
3) clean surgery,
4) patient with a good command of Japanese,
5) who were able to give consent on their own or through relatives,
6) who had a primary intention wound closure.
Key exclusion criteria 1) operations involving use of external fixations,
2) amputations,
3) needle biopsies,
4) implant removal,
5) reconstructive surgery involving skin tissue such as flap surgery,
6) patients receiving antibiotic therapy prior to surgery,
7) percutaneous vertebroplasty (balloon kyphoplasty, vertebroplasty, etc.)
8) procedures performed in collaboration with other departments.
Target sample size 1000

Research contact person
Name of lead principal investigator
1st name Hiroshi
Middle name
Last name Okazaki
Organization Kanto Rosai Hospital
Division name Department of orthopedic surgery
Zip code 211-8510
Address 1-1 Kizukisumiyoshi-cho, Nakahara-ku , Kawasaki City, Kanagawa Prefecture, Japan
TEL 044-411-3131
Email okazarov@kantoh.johas.go.jp

Public contact
Name of contact person
1st name Kosei
Middle name
Last name Nagata
Organization the University of Tokyo Hospital
Division name Department of Orthopaedic Surgery and Spinal Surgery
Zip code 112-8655
Address 7-3-1Hongo, Bunkyo-ku, Tokyo, Japan
TEL 03-3815-5411
Homepage URL http://ossi.jp/about/
Email knagata-tky@umin.ac.jp

Sponsor
Institute Society for Orthopaedic Surgical Site Infection
Institute
Department

Funding Source
Organization Tokyo Metropolitan Government
Organization
Division
Category of Funding Organization Local Government
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Japan Organization of Occupational Health and Safety Kanto Rosai Hospital
Address 1-1 Kizukisumiyoshi-cho, Nakahara-ku , Kawasaki City, Kanagawa Prefecture, Japan
Tel 044-411-3131
Email ossijapan@gmail.com

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 東京都立広尾病院(東京都)
関東労災病院(神奈川県)
東京都立駒込病院(東京都)
東京都立多摩総合病院整形外科(東京都)
東京都健康長寿医療センター(東京都)

Other administrative information
Date of disclosure of the study information
2018 Year 04 Month 01 Day

Related information
URL releasing protocol http://ossi.jp/info/
Publication of results Unpublished

Result
URL related to results and publications http://ossi.jp/info/
Number of participants that the trial has enrolled 1232
Results The SSI and HAI rate may be equivalent between Group 24 and Group 48.
Results date posted
2019 Year 08 Month 01 Day
Results Delayed
Delay expected
Results Delay Reason The statistical analysis will need long time.
Date of the first journal publication of results
2020 Year 08 Month 30 Day
Baseline Characteristics (1) age more than 20 years; (2) hospitalized patients; (3) patients who underwent clean surgery based on CDC wound classification system; (4) patients with a good command of the Japanese language; (5) patients able to give consent on their own or through relatives; and (6) a primary intention wound closure.
Participant flow In this study, patients will be divided into two groups of different AMP duration using the institution-by-period cluster allocation system. Patients will not be informed of allocation schedule preoperatively.
Adverse events Adverse events, including anaphylaxis, will not be observed.
Outcome measures Patients' background and (1) SSI, (2) UTI, (3) RTI, or (4) other infectious diseases. Secondary outcomes will include the prevalence of diseases (1)-(4), (5)mortality, (6) cardiovascular events observed within 30 days after surgery, (7) prolonged hospitalization for >30 days, and (8) the rate of antibiotic resistance of SSI pathogens.
Plan to share IPD no
IPD sharing Plan description no

Progress
Recruitment status Main results already published
Date of protocol fixation
2018 Year 05 Month 01 Day
Date of IRB
2017 Year 02 Month 01 Day
Anticipated trial start date
2018 Year 05 Month 01 Day
Last follow-up date
2019 Year 10 Month 31 Day
Date of closure to data entry
2019 Year 10 Month 31 Day
Date trial data considered complete
2019 Year 10 Month 31 Day
Date analysis concluded
2019 Year 12 Month 31 Day

Other
Other related information The patient registration was terminated on December 31, 2018. Data were fixed around June 30, 2019. In order to evaluate the onset of infection within 30 days after surgery. Data analysis was conducted by the end of March 2020.Submission will be performed by August 2020.

Management information
Registered date
2018 Year 01 Month 22 Day
Last modified on
2022 Year 01 Month 25 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000035321